Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Leyre Oteiza Zubiri, M.D., Ph.D.

Concepts (157)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms162022216750.560 Why?
Myocarditis520227680.490 Why?
Melanoma10202355080.480 Why?
Immunotherapy4202144370.450 Why?
Cross Infection1202114160.410 Why?
Exanthema220245010.330 Why?
Thyroiditis12021850.200 Why?
Colitis2201911700.190 Why?
Hypokalemia120211530.190 Why?
Lymphatic Diseases120223230.180 Why?
Extracellular Matrix Proteins220158500.180 Why?
Censuses120212000.180 Why?
Enterocolitis120201020.170 Why?
Pericardial Effusion120212470.170 Why?
Hyponatremia120212970.160 Why?
Lymphocyte Count120207930.160 Why?
Ablation Techniques120212490.150 Why?
Carcinoma, Non-Small-Cell Lung3202252300.150 Why?
Anemia, Hemolytic, Autoimmune120191420.150 Why?
Budgets120192290.150 Why?
Renin-Angiotensin System120227580.150 Why?
Retrospective Studies222023774100.150 Why?
Lung Neoplasms42022131120.140 Why?
Drug Eruptions120192970.140 Why?
Intramolecular Oxidoreductases120151090.130 Why?
Heart Conduction System1202110470.130 Why?
Inpatients3202125150.130 Why?
Chemistry, Clinical12015630.120 Why?
Neoplasms, Second Primary1202210630.120 Why?
Adrenal Cortex Hormones2202018540.120 Why?
Celiac Disease120227850.120 Why?
Proto-Oncogene Proteins B-raf2201420390.120 Why?
Skin Neoplasms3202356910.120 Why?
Combined Modality Therapy3202286370.120 Why?
Humans4520247438110.120 Why?
Action Potentials1202118040.110 Why?
Patient Admission1202113800.110 Why?
Middle Aged2320222132410.110 Why?
S100 Proteins120132590.110 Why?
Brachytherapy1202112470.110 Why?
Hemoglobins1201915310.110 Why?
Neoplasm Proteins2201537060.100 Why?
Male2720223497760.100 Why?
Aged2020221631780.100 Why?
Drug Costs1201911050.100 Why?
Exosomes120154190.100 Why?
Embolization, Therapeutic1202113920.100 Why?
Nervous System Diseases1202116190.090 Why?
Pneumonia1202221330.090 Why?
Heart Rate1202140910.090 Why?
Plaque, Atherosclerotic1202015180.080 Why?
Neutrophils1202037180.080 Why?
Female2220223800200.080 Why?
Electrocardiography1202164410.070 Why?
Renal Insufficiency, Chronic1202122000.070 Why?
Acute Kidney Injury1201919680.070 Why?
Cohort Studies72023405450.070 Why?
Incidence52023209480.070 Why?
DNA Mutational Analysis1201441830.070 Why?
Risk Factors92022722520.070 Why?
Polymerase Chain Reaction1201461700.060 Why?
Liver1202074790.060 Why?
Atherosclerosis1202034450.060 Why?
Radioimmunotherapy12024910.060 Why?
Practice Guidelines as Topic1202172700.060 Why?
Pandemics2202183850.060 Why?
Aged, 80 and over72022577440.060 Why?
DNA2201572950.060 Why?
Neoplasm Staging42019110360.060 Why?
Genome-Wide Association Study12022122590.060 Why?
Consensus2202429540.060 Why?
L-Lactate Dehydrogenase220154240.060 Why?
Treatment Outcome52021630420.050 Why?
Glomerular Filtration Rate2202121670.050 Why?
Interleukin-7120221420.050 Why?
Coronavirus Infections1202031340.050 Why?
Pneumonia, Viral1202032410.050 Why?
Time Factors52021400380.050 Why?
Antibodies, Monoclonal1201992720.050 Why?
Hypertension1202284800.050 Why?
Drug Administration Schedule2202049310.050 Why?
Predictive Value of Tests32022150670.050 Why?
Electrolytes120212820.050 Why?
Antineoplastic Agents22020136910.040 Why?
Takotsubo Cardiomyopathy120211240.040 Why?
Risk Assessment42021233270.040 Why?
Myocardial Infarction12020117080.040 Why?
Azithromycin120201960.040 Why?
Biopsy2202167500.040 Why?
Germ Cells120226290.040 Why?
Cardiac Imaging Techniques120212690.040 Why?
Massachusetts2202186600.040 Why?
Prognosis42020290520.040 Why?
Troponin T120227540.040 Why?
Tomography, X-Ray Computed12020201210.040 Why?
Disease-Free Survival2202068950.040 Why?
Hospitalization32021102590.040 Why?
Myocardial Revascularization120208410.030 Why?
Hydroxychloroquine120204120.030 Why?
Sodium1202116220.030 Why?
Neoplasm Metastasis2201948480.030 Why?
Angiotensin Receptor Antagonists120229230.030 Why?
Markov Chains120199680.030 Why?
Databases, Factual2202177290.030 Why?
Angiotensin-Converting Enzyme Inhibitors1202215160.030 Why?
Registries2202180900.030 Why?
Ligands1202232810.030 Why?
Models, Economic120197120.030 Why?
Proton Pump Inhibitors120195260.030 Why?
Creatinine1201919180.030 Why?
Oximes120143110.030 Why?
Disease Progression22020132730.030 Why?
ROC Curve1202035270.030 Why?
Quality-Adjusted Life Years1201916830.030 Why?
Immunotherapy, Adoptive1202112710.030 Why?
Antihypertensive Agents1202220470.030 Why?
Adult620222138890.030 Why?
Mutation12014297770.020 Why?
Academic Medical Centers1202027600.020 Why?
Patient Care Team1202125280.020 Why?
Ventricular Function, Left1202236600.020 Why?
Cause of Death1202035800.020 Why?
Stroke Volume1202250020.020 Why?
Glucocorticoids1201921070.020 Why?
Decision Support Techniques1201919560.020 Why?
Imidazoles1201412060.020 Why?
Skin1202243720.020 Why?
Neoplastic Cells, Circulating120159330.020 Why?
Immunosuppressive Agents1202141520.020 Why?
Dose-Response Relationship, Drug12020109400.020 Why?
Molecular Targeted Therapy1201927270.020 Why?
Antiviral Agents1202029840.020 Why?
Intensive Care Units1202136790.020 Why?
MAP Kinase Signaling System1201515240.020 Why?
Boston1202093100.020 Why?
Prospective Studies22022532500.020 Why?
Indoles1201418410.020 Why?
Cost-Benefit Analysis1201953880.020 Why?
Kidney1202171850.020 Why?
Comorbidity12020103800.020 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors1202032550.020 Why?
Cognition1202267590.020 Why?
Sulfonamides1201419380.020 Why?
Survival Rate12019127860.020 Why?
Kaplan-Meier Estimate1201465390.010 Why?
Case-Control Studies12020217330.010 Why?
United States22021698590.010 Why?
Proteomics1201536390.010 Why?
Severity of Illness Index12019155260.010 Why?
Cytokines1201573240.010 Why?
Cell Line, Tumor12015166740.010 Why?
Quality of Life12019127880.010 Why?
Protein Kinase Inhibitors1201355320.010 Why?
Young Adult12022563920.010 Why?
Cardiovascular Diseases12020151420.010 Why?
Follow-Up Studies12014390010.010 Why?
Adolescent12019857290.010 Why?
Zubiri's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (157)
Explore
_
Co-Authors (133)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.